Gilead Sciences Inc
GILD
$119.41+9.13 (+8.28%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 121.38 | 52Week Low | 72.43 |
| Beta | 0.36 | Current Ratio Annual | 1.60 |
| Current Ratio Quarterly | 1.32 | Gross Margin TTM | 78.53 |
| Market Cap | 148.54B | Net Profit Margin TTM | 21.87 |
| Operating Margin TTM | 27.89 | Price To Book | 7.55 |
| Price To Earnings TTM | 23.54 | Price To Free Cash Flow TTM | 16.26 |
| Price To Sales TTM | 5.15 | Quick Ratio Annual | 1.20 |
| Quick Ratio Quarterly | 0.89 | Return On Assets TTM | 11.19 |
| Return On Equity TTM | 32.97 | Return On Investment TTM | 16.48 |
| Revenue Growth3Y | 1.74 | Revenue Growth5Y | 5.08 |
| Revenue Growth Quarterly Yoy | 1.84 | Revenue Growth TTMYoy | 3.81 |
| Revenue Per Share TTM | 23.00 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1921 | 247 | 170 | 648 | 783 | 204 | 1.06B | $112.46B |
| Jun 30, 2025 | 1210 | 68 | 77 | 477 | 413 | 163 | 157.12M | $15.62B |
| Change | 711(37%) | 179(72%) | 93(55%) | 171(26%) | 370(47%) | 41(20%) | 902.90M(85%) | $96.84B(86%) |